Evidence map›Paper›PMID 40311072›Full record

ArticleBlood advances2025

Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term results.

Bruce D Cheson, Nancy L Bartlett, Betsy Knopf, Hun J Lee, Ranjana H Advani, Beth Christian, Catherine S Diefenbach, Tatyana A Feldman, Stephen M Ansell

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bruce D ChesonCenter for Cancer and Blood Disorders, Bethesda, MD.
Nancy L BartlettDivision of Oncology, Department of Medicine, Siteman Cancer Center, Washington University School of Medicine, St Louis, MO.
Betsy KnopfDivision of Biomedical Statistics and Bioinformatics, Department of Health Sciences Research Medicine, Mayo Clinic, Rochester, MN.
Hun J LeeDepartment of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX.ORCID 0000-0001-7219-5562
Ranjana H AdvaniDivision of Oncology, Stanford Cancer Institute, Stanford, CA.
Beth ChristianDivision of Hematology, The Ohio State University Cancer Center, Columbus, OH.
Catherine S DiefenbachDivision of Hematologic Malignancies, Clinical Lymphoma Program, Perlmutter Cancer Center at New York University Langone Health, New York, NY.ORCID 0000-0003-1116-3246
Tatyana A FeldmanLymphoma Division, Hackensack University Medical Center, Hackensack, NJ.
Stephen M AnsellDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40311072
PMCPMC12305559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.